Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin

Disseminated intravascular coagulation (DIC) in patients with sepsis represents a critical condition. Thus, a simple and rapid diagnosis is required. The purpose of this study was to compare the performances of a recently developed Sepsis-Induced Coagulopathy (SIC) with the Japanese Association for...

Full description

Saved in:
Bibliographic Details
Published inClinical and applied thrombosis/hemostasis Vol. 24; no. 7; pp. 1020 - 1026
Main Authors Iba, Toshiaki, Arakawa, Makoto, Levy, Jerrold H., Yamakawa, Kazuma, Koami, Hiroyuki, Hifumi, Toru, Sato, Koichi
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.10.2018
SAGE PUBLICATIONS, INC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disseminated intravascular coagulation (DIC) in patients with sepsis represents a critical condition. Thus, a simple and rapid diagnosis is required. The purpose of this study was to compare the performances of a recently developed Sepsis-Induced Coagulopathy (SIC) with the Japanese Association for Acute Medicine (JAAM) DIC. Four hundred nine patients with sepsis having coagulopathy and antithrombin activity of less than 70% and treated with antithrombin were retrospectively analyzed, and the SIC and JAAM-DIC criteria on days 1 (before treatment), 2, 4, and 7 were compared. The prevalence of JAAM-DIC on day 1 was significantly higher than that of SIC (91.4% vs 81.8%, P = .003), but there were no differences on days 2, 4, and 7. The mortality rates in the SIC and JAAM-DIC groups were both 23.3%. The specificity to 28-day mortality on day 1 was higher in the SIC group (15.8% vs 9.2%, P = .013). There were no differences in sensitivity on days 1, 2, 4, and 7. Mortality was significantly different between SIC-positive and SIC-negative groups on days 2, 4, and 7 (P < .01, respectively), while significant differences were seen between JAAM-DIC-positive and JAAM-DIC-negative groups only on days 4 and 7 (P < .05, .01, respectively). In summary, the SIC characteristics were similar to the JAAM-DIC group, and the classifications were comparable in terms of mortality prediction. The SIC scoring system is simple, easy to use, and adaptable to the new sepsis definitions and offers an important approach to evaluating patients in emergency and critical care settings.
AbstractList Disseminated intravascular coagulation (DIC) in patients with sepsis represents a critical condition. Thus, a simple and rapid diagnosis is required. The purpose of this study was to compare the performances of a recently developed Sepsis-Induced Coagulopathy (SIC) with the Japanese Association for Acute Medicine (JAAM) DIC. Four hundred nine patients with sepsis having coagulopathy and antithrombin activity of less than 70% and treated with antithrombin were retrospectively analyzed, and the SIC and JAAM-DIC criteria on days 1 (before treatment), 2, 4, and 7 were compared. The prevalence of JAAM-DIC on day 1 was significantly higher than that of SIC (91.4% vs 81.8%, P = .003), but there were no differences on days 2, 4, and 7. The mortality rates in the SIC and JAAM-DIC groups were both 23.3%. The specificity to 28-day mortality on day 1 was higher in the SIC group (15.8% vs 9.2%, P = .013). There were no differences in sensitivity on days 1, 2, 4, and 7. Mortality was significantly different between SIC-positive and SIC-negative groups on days 2, 4, and 7 ( P < .01, respectively), while significant differences were seen between JAAM-DIC-positive and JAAM-DIC-negative groups only on days 4 and 7 ( P < .05, .01, respectively). In summary, the SIC characteristics were similar to the JAAM-DIC group, and the classifications were comparable in terms of mortality prediction. The SIC scoring system is simple, easy to use, and adaptable to the new sepsis definitions and offers an important approach to evaluating patients in emergency and critical care settings.Disseminated intravascular coagulation (DIC) in patients with sepsis represents a critical condition. Thus, a simple and rapid diagnosis is required. The purpose of this study was to compare the performances of a recently developed Sepsis-Induced Coagulopathy (SIC) with the Japanese Association for Acute Medicine (JAAM) DIC. Four hundred nine patients with sepsis having coagulopathy and antithrombin activity of less than 70% and treated with antithrombin were retrospectively analyzed, and the SIC and JAAM-DIC criteria on days 1 (before treatment), 2, 4, and 7 were compared. The prevalence of JAAM-DIC on day 1 was significantly higher than that of SIC (91.4% vs 81.8%, P = .003), but there were no differences on days 2, 4, and 7. The mortality rates in the SIC and JAAM-DIC groups were both 23.3%. The specificity to 28-day mortality on day 1 was higher in the SIC group (15.8% vs 9.2%, P = .013). There were no differences in sensitivity on days 1, 2, 4, and 7. Mortality was significantly different between SIC-positive and SIC-negative groups on days 2, 4, and 7 ( P < .01, respectively), while significant differences were seen between JAAM-DIC-positive and JAAM-DIC-negative groups only on days 4 and 7 ( P < .05, .01, respectively). In summary, the SIC characteristics were similar to the JAAM-DIC group, and the classifications were comparable in terms of mortality prediction. The SIC scoring system is simple, easy to use, and adaptable to the new sepsis definitions and offers an important approach to evaluating patients in emergency and critical care settings.
Disseminated intravascular coagulation (DIC) in patients with sepsis represents a critical condition. Thus, a simple and rapid diagnosis is required. The purpose of this study was to compare the performances of a recently developed Sepsis-Induced Coagulopathy (SIC) with the Japanese Association for Acute Medicine (JAAM) DIC. Four hundred nine patients with sepsis having coagulopathy and antithrombin activity of less than 70% and treated with antithrombin were retrospectively analyzed, and the SIC and JAAM-DIC criteria on days 1 (before treatment), 2, 4, and 7 were compared. The prevalence of JAAM-DIC on day 1 was significantly higher than that of SIC (91.4% vs 81.8%, P = .003), but there were no differences on days 2, 4, and 7. The mortality rates in the SIC and JAAM-DIC groups were both 23.3%. The specificity to 28-day mortality on day 1 was higher in the SIC group (15.8% vs 9.2%, P = .013). There were no differences in sensitivity on days 1, 2, 4, and 7. Mortality was significantly different between SIC-positive and SIC-negative groups on days 2, 4, and 7 (P < .01, respectively), while significant differences were seen between JAAM-DIC-positive and JAAM-DIC-negative groups only on days 4 and 7 (P < .05, .01, respectively). In summary, the SIC characteristics were similar to the JAAM-DIC group, and the classifications were comparable in terms of mortality prediction. The SIC scoring system is simple, easy to use, and adaptable to the new sepsis definitions and offers an important approach to evaluating patients in emergency and critical care settings.
Disseminated intravascular coagulation (DIC) in patients with sepsis represents a critical condition. Thus, a simple and rapid diagnosis is required. The purpose of this study was to compare the performances of a recently developed Sepsis-Induced Coagulopathy (SIC) with the Japanese Association for Acute Medicine (JAAM) DIC. Four hundred nine patients with sepsis having coagulopathy and antithrombin activity of less than 70% and treated with antithrombin were retrospectively analyzed, and the SIC and JAAM-DIC criteria on days 1 (before treatment), 2, 4, and 7 were compared. The prevalence of JAAM-DIC on day 1 was significantly higher than that of SIC (91.4% vs 81.8%, P = .003), but there were no differences on days 2, 4, and 7. The mortality rates in the SIC and JAAM-DIC groups were both 23.3%. The specificity to 28-day mortality on day 1 was higher in the SIC group (15.8% vs 9.2%, P = .013). There were no differences in sensitivity on days 1, 2, 4, and 7. Mortality was significantly different between SIC-positive and SIC-negative groups on days 2, 4, and 7 ( P < .01, respectively), while significant differences were seen between JAAM-DIC-positive and JAAM-DIC-negative groups only on days 4 and 7 ( P < .05, .01, respectively). In summary, the SIC characteristics were similar to the JAAM-DIC group, and the classifications were comparable in terms of mortality prediction. The SIC scoring system is simple, easy to use, and adaptable to the new sepsis definitions and offers an important approach to evaluating patients in emergency and critical care settings.
Author Hifumi, Toru
Iba, Toshiaki
Koami, Hiroyuki
Arakawa, Makoto
Yamakawa, Kazuma
Sato, Koichi
Levy, Jerrold H.
AuthorAffiliation 2 Department of Anesthesiology and Critical Care, Duke University School of Medicine, Durham, NC, USA
3 Department of Emergency and Critical Care, Osaka General Medical Center, Osaka, Japan
4 Department of Emergency and Critical Care Medicine, Saga University, Saga, Japan
6 Department of Surgery, Juntendo Shizuoka Hospital, Juntendo University Graduate School of Medicine, Tokyo, Japan
5 Emergency Medical Center, Kagawa University Hospital, Kagawa, Japan
1 Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
AuthorAffiliation_xml – name: 6 Department of Surgery, Juntendo Shizuoka Hospital, Juntendo University Graduate School of Medicine, Tokyo, Japan
– name: 2 Department of Anesthesiology and Critical Care, Duke University School of Medicine, Durham, NC, USA
– name: 4 Department of Emergency and Critical Care Medicine, Saga University, Saga, Japan
– name: 5 Emergency Medical Center, Kagawa University Hospital, Kagawa, Japan
– name: 1 Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
– name: 3 Department of Emergency and Critical Care, Osaka General Medical Center, Osaka, Japan
Author_xml – sequence: 1
  givenname: Toshiaki
  orcidid: 0000-0002-0255-4088
  surname: Iba
  fullname: Iba, Toshiaki
  email: toshiiba@cf6.so-net.ne.jp
– sequence: 2
  givenname: Makoto
  surname: Arakawa
  fullname: Arakawa, Makoto
– sequence: 3
  givenname: Jerrold H.
  surname: Levy
  fullname: Levy, Jerrold H.
– sequence: 4
  givenname: Kazuma
  surname: Yamakawa
  fullname: Yamakawa, Kazuma
– sequence: 5
  givenname: Hiroyuki
  orcidid: 0000-0001-6268-4602
  surname: Koami
  fullname: Koami, Hiroyuki
– sequence: 6
  givenname: Toru
  surname: Hifumi
  fullname: Hifumi, Toru
– sequence: 7
  givenname: Koichi
  surname: Sato
  fullname: Sato, Koichi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29695178$$D View this record in MEDLINE/PubMed
BookMark eNp9kstuEzEUhi1URC-wZ4UssWEz4MvMeLxBilIKQUUgUdaWL2cSVxM72DOgPEzfFYeU0kaCla3zf_-52OcUHYUYAKHnlLymVIg3lIiWMNnSTgjCBH-ETqjkXcUE40flXuRqpx-j05yvCaGyle0TdFxCsqGiO0E3X2GTfa4WwU0WHJ5HvZyGuNHjaot1cPij3ugAGfAs52i9Hn0MuI8Jz-w0Av4EzlsfAJ8v5tiH-35v8ZeCQxgz_unHFT4Hm0DnUmUWxhJIcW2KZVflqghjEcz2gfYUPe71kOHZ7XmGvl28u5p_qC4_v1_MZ5eVrVs2VmA0AyqhMZoDc8xIwjoJ1BHeEW25sTWhtZGGuV6aphWWut51TACTja4ZP0Nv93k3k1mDs6XnpAe1SX6t01ZF7dVDJfiVWsYfqhW0Fg0pCV7dJkjx-wR5VGufLQxDebs4ZcUIpzVtZM0L-vIAvY5TCmU8xTjlgnZt1xTqxf2O7lr583MFIHvApphzgv4OoUTtlkMdLkextAcW68ffH1pm8sP_jNXemPUS_rb7T_4Xl_HMag
CitedBy_id crossref_primary_10_3389_fcvm_2021_729298
crossref_primary_10_1007_s12185_021_03152_4
crossref_primary_10_3389_fmed_2021_773339
crossref_primary_10_12677_acm_2024_1451424
crossref_primary_10_3389_fped_2024_1336583
crossref_primary_10_1007_s11908_024_00833_z
crossref_primary_10_3389_fmed_2020_637434
crossref_primary_10_5812_zjrms_121045
crossref_primary_10_3390_life13020350
crossref_primary_10_3390_healthcare11020227
crossref_primary_10_1371_journal_pone_0315797
crossref_primary_10_3389_fimmu_2022_1026163
crossref_primary_10_3389_fcvm_2021_724942
crossref_primary_10_1002_ams2_411
crossref_primary_10_1177_10760296241271334
crossref_primary_10_1111_jth_14482
crossref_primary_10_1007_s00101_021_00916_9
crossref_primary_10_1055_s_0040_1718736
crossref_primary_10_1177_10760296231195089
crossref_primary_10_1016_j_arcmed_2021_07_003
crossref_primary_10_1055_a_2530_7553
crossref_primary_10_1177_10760296231207630
crossref_primary_10_25284_2519_2078_2_95__2021_238302
crossref_primary_10_1186_s13613_022_01093_7
crossref_primary_10_1186_s40560_023_00672_5
crossref_primary_10_1097_MD_0000000000037634
crossref_primary_10_1093_eurheartj_ehad388
crossref_primary_10_1186_s12879_024_09154_x
crossref_primary_10_2491_jjsth_35_384
crossref_primary_10_1111_jth_14578
crossref_primary_10_1111_jth_15500
crossref_primary_10_1016_j_jtha_2022_10_022
crossref_primary_10_1177_10760296231157766
crossref_primary_10_3390_cells12172120
Cites_doi 10.1111/j.1538-7836.2005.01697.x
10.1111/jth.12643
10.1055/s-0037-1616068
10.1016/j.jiac.2013.07.006
10.1160/TH15-01-0053
10.1186/s13054-015-0810-3
10.1097/01.CCM.0000202209.42491.38
10.1001/jama.2016.0287
10.1186/s40560-016-0169-9
10.1007/s00134-016-4621-z
10.1007/s12185-015-1904-z
10.1097/01.CCM.0000181296.53204.DE
10.1111/jth.12596
10.1055/s-2001-18867
10.1186/s13054-016-1468-1
10.1111/jth.13230
10.1111/j.1538-7836.2004.00955.x
10.1186/s13054-016-1415-1
10.1016/j.thromres.2014.07.033
10.1038/nrdp.2016.37
10.1016/j.thromres.2008.07.006
10.1097/01.CCM.0000295317.97245.2D
10.1016/j.thromres.2009.08.017
10.1136/bmjopen-2017-017046
10.1007/s00134-016-4607-x
ContentType Journal Article
Copyright The Author(s) 2018
The Author(s) 2018. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2018 2018 SAGE Publications Inc. unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
Copyright_xml – notice: The Author(s) 2018
– notice: The Author(s) 2018. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2018 2018 SAGE Publications Inc. unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
DBID AFRWT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1177/1076029618770273
DatabaseName Sage Journals GOLD Open Access 2024
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database
MEDLINE


CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: AFRWT
  name: Sage Journals GOLD Open Access 2024
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
– sequence: 4
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1938-2723
EndPage 1026
ExternalDocumentID PMC6714750
29695178
10_1177_1076029618770273
10.1177_1076029618770273
Genre Multicenter Study
Journal Article
GrantInformation_xml – fundername: Ministry of Education, Culture, Sports, Science and Technology-Supported Program for the Strategic Research Foundation at Private Universities 2017
– fundername: ;
GroupedDBID ---
-TM
.2F
.2G
01A
0R~
29B
31S
31Y
36B
4.4
53G
54M
5GY
5VS
7X7
8FI
8FJ
AABMB
AACKU
AADUE
AAGGD
AAJIQ
AAJOX
AAJPV
AANSI
AAPEO
AAQDB
AAQGT
AAQXH
AARDL
AARIX
AASGM
AAXOT
AAYTG
AAZBJ
ABAWP
ABDWY
ABEIX
ABFWQ
ABHKI
ABJIS
ABKRH
ABPGX
ABQKF
ABQXT
ABRHV
ABUWG
ABVFX
ABVVC
ABXGC
ABYTW
ACARO
ACDSZ
ACDXX
ACFMA
ACFYK
ACGBL
ACGFS
ACLHI
ACOFE
ACROE
ACRPL
ADBBV
ADEBD
ADEIA
ADMPF
ADNBR
ADNMO
ADOGD
ADSTG
ADTBJ
ADUKL
ADYCS
ADZZY
AECVZ
AENEX
AEQLS
AERKM
AEUHG
AEWDL
AEXFG
AEXNY
AFCOW
AFEET
AFKBI
AFKRA
AFKRG
AFRWT
AFUIA
AFWMB
AGNHF
AGQPQ
AHHFK
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
B8M
B8O
B93
BDDNI
BENPR
BKSCU
BPHCQ
BSEHC
BVXVI
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
DC-
DC.
DC0
DD-
DD0
DE-
DOPDO
DU5
D~Y
EBS
EJD
EMB
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HMCUK
HVGLF
HYE
HZ~
J8X
K.F
K.J
N9A
O9-
OK1
OVD
P.B
PHGZM
PHGZT
PIMPY
PQQKQ
Q1R
Q7K
Q7R
Q7X
Q82
RIG
ROL
RPM
S01
SAUOL
SCDPB
SCNPE
SFB
SFC
SFN
SGA
SGP
SGX
SQCSI
SV3
TEORI
UKHRP
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
ACHEB
CITATION
CGR
CUY
CVF
ECM
EIF
M4V
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c462t-eba2e19e5ba3e2d2b90289e1d0380ac3bc4014b9b2df9b567c1dfd827e295a423
IEDL.DBID AFRWT
ISSN 1076-0296
1938-2723
IngestDate Thu Aug 21 18:41:31 EDT 2025
Fri Jul 11 00:34:33 EDT 2025
Mon Jun 30 13:19:27 EDT 2025
Thu Apr 03 07:08:18 EDT 2025
Tue Jul 01 05:23:37 EDT 2025
Thu Apr 24 23:07:03 EDT 2025
Tue Jun 17 22:47:10 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords platelet count
prothrombin time
diagnostic criteria
disseminated intravascular coagulation
sepsis
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-eba2e19e5ba3e2d2b90289e1d0380ac3bc4014b9b2df9b567c1dfd827e295a423
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6268-4602
0000-0002-0255-4088
OpenAccessLink https://journals.sagepub.com/doi/full/10.1177/1076029618770273?utm_source=summon&utm_medium=discovery-provider
PMID 29695178
PQID 2313718685
PQPubID 4450586
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6714750
proquest_miscellaneous_2031415943
proquest_journals_2313718685
pubmed_primary_29695178
crossref_primary_10_1177_1076029618770273
crossref_citationtrail_10_1177_1076029618770273
sage_journals_10_1177_1076029618770273
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-10-01
PublicationDateYYYYMMDD 2018-10-01
PublicationDate_xml – month: 10
  year: 2018
  text: 2018-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Los Angeles, CA
PublicationPlace_xml – name: Los Angeles, CA
– name: United States
– name: Thousand Oaks
– name: Sage CA: Los Angeles, CA
PublicationTitle Clinical and applied thrombosis/hemostasis
PublicationTitleAlternate Clin Appl Thromb Hemost
PublicationYear 2018
Publisher SAGE Publications
SAGE PUBLICATIONS, INC
Publisher_xml – name: SAGE Publications
– name: SAGE PUBLICATIONS, INC
References Ogura, Gando, Saitoh 2014; 20
Gando, Saitoh, Ogura 2008; 36
Tagami, Matsui, Horiguchi 2014; 12
Yamakawa, Umemura, Hayakawa 2016
Umemura, Yamakawa, Ogura 2016; 14
Kienast, Juers, Wiedermann 2006; 4
Taylor, Toh, Hoots 2001; 86
Gando, Iba, Eguchi, Ohtomo 2006; 34
Iba, Thachil 2016; 103
Wada, Asakura, Okamoto 2010; 125
Iba, Gando, Thachil 2014; 12
Yoshimura, Yamakawa, Ogura 2015; 19
van der Poll, Opal 2017; 43
Meziani, Gando, Vincent 2017; 43
Gando, Saitoh, Ogura 2009; 123
Taylor, Kosanke, Randolph 1994; 42
Dhainaut, Yan, Joyce 2004; 2
Iba, Di Nisio, Levy 2017; 7
Wada, Okamoto, Iba 2014; 134
Hayakawa, Saito, Uchino 2016; 4
Iba, Di Nisio, Thachil 2016; 20
Kinasewitz, Zein, Lee 2005; 33
Gando, Levi, Toh 2016; 2
Singer, Deutschman, Seymour 2016; 315
Tagami, Matsui, Fushimi 2015; 114
Hack 2001; 27
bibr12-1076029618770273
bibr25-1076029618770273
bibr17-1076029618770273
bibr20-1076029618770273
bibr9-1076029618770273
bibr21-1076029618770273
bibr3-1076029618770273
bibr16-1076029618770273
Taylor FB (bibr14-1076029618770273) 1994; 42
bibr18-1076029618770273
bibr4-1076029618770273
bibr22-1076029618770273
bibr8-1076029618770273
bibr26-1076029618770273
bibr13-1076029618770273
bibr1-1076029618770273
bibr23-1076029618770273
bibr19-1076029618770273
bibr5-1076029618770273
bibr10-1076029618770273
bibr7-1076029618770273
bibr24-1076029618770273
bibr2-1076029618770273
bibr15-1076029618770273
bibr11-1076029618770273
bibr6-1076029618770273
References_xml – volume: 4
  start-page: 44
  year: 2016
  article-title: Characteristics, treatments, and outcomes of severe sepsis of 3195 ICU-treated adult patients throughout Japan during 2011-2013
  publication-title: J Intensive Care
– volume: 12
  start-page: 1010
  issue: 7
  year: 2014
  end-page: 1019
  article-title: Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan
  publication-title: J Thromb Haemost
– volume: 33
  start-page: 2214
  issue: 10
  year: 2005
  end-page: 2221
  article-title: Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis
  publication-title: Crit Care Med
– volume: 34
  start-page: 625
  issue: 3
  year: 2006
  end-page: 631
  article-title: A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria
  publication-title: Crit Care Med
– volume: 114
  start-page: 537
  issue: 3
  year: 2015
  end-page: 545
  article-title: Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis
  publication-title: Thromb Haemost
– volume: 2
  start-page: 16037
  year: 2016
  article-title: Disseminated intravascular coagulation
  publication-title: Nat Rev Dis Primers
– volume: 12
  start-page: 1470
  issue: 9
  year: 2014
  end-page: 1479
  article-title: Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study
  publication-title: J Thromb Haemost
– volume: 19
  start-page: 810
  year: 2015
  article-title: Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
  publication-title: Crit Care
– volume: 4
  start-page: 90
  issue: 1
  year: 2006
  end-page: 97
  article-title: Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation
  publication-title: J Thromb Haemost
– volume: 134
  start-page: 924
  issue: 4
  year: 2014
  end-page: 925
  article-title: Addition of recommendations for the use of recombinant human thrombomodulin to the “Expert consensus for the treatment of disseminated intravascular coagulation in Japan
  publication-title: Thromb Res
– volume: 2
  start-page: 1924
  issue: 11
  year: 2004
  end-page: 1933
  article-title: Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation
  publication-title: J Thromb Haemost
– issue: 1
  year: 2016
  article-title: Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan
  publication-title: Crit Care 20 229
– volume: 36
  start-page: 145
  issue: 1
  year: 2008
  end-page: 150
  article-title: Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey
  publication-title: Crit Care Med
– volume: 14
  start-page: 518
  issue: 3
  year: 2016
  end-page: 530
  article-title: Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials
  publication-title: J Thromb Haemost
– volume: 20
  start-page: 157
  issue: 3
  year: 2014
  end-page: 162
  article-title: Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study
  publication-title: J Infect Chemother
– volume: 42
  start-page: 92
  issue: 2
  year: 1994
  end-page: 103
  article-title: Retrospective description and experimental reconstitution of three different responses of the baboon to lethal
  publication-title: Circ Shock
– volume: 103
  start-page: 253
  issue: 3
  year: 2016
  end-page: 261
  article-title: Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan
  publication-title: Int J Hematol
– volume: 315
  start-page: 801
  issue: 8
  year: 2016
  end-page: 810
  article-title: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
  publication-title: JAMA
– volume: 27
  start-page: 633
  issue: 6
  year: 2001
  end-page: 638
  article-title: Fibrinolysis in disseminated intravascular coagulation
  publication-title: Semin Thromb Hemost
– volume: 7
  start-page: e017046
  issue: 9
  year: 2017
  article-title: New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition
  publication-title: BMJ Open
– volume: 86
  start-page: 1327
  issue: 5
  year: 2001
  end-page: 1330
  article-title: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation
  publication-title: Thromb Haemost
– volume: 43
  start-page: 452
  issue: 3
  year: 2017
  end-page: 454
  article-title: Should all patients with sepsis receive anticoagulation? Yes
  publication-title: Intensive Care Med
– volume: 123
  start-page: 715
  issue: 5
  year: 2009
  end-page: 718
  article-title: Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis
  publication-title: Thromb Res
– volume: 125
  start-page: 6
  issue: 1
  year: 2010
  end-page: 11
  article-title: Expert consensus for the treatment of disseminated intravascular coagulation in Japan
  publication-title: Thromb Res
– volume: 43
  start-page: 455
  issue: 3
  year: 2017
  end-page: 457
  article-title: Should all septic patients be given systemic anticoagulation? No
  publication-title: Intensive Care Med
– volume: 20
  start-page: 287
  year: 2016
  article-title: Revision of the Japanese Association for Acute Medicine (JAAM)-disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity
  publication-title: Crit Care
– ident: bibr5-1076029618770273
  doi: 10.1111/j.1538-7836.2005.01697.x
– ident: bibr9-1076029618770273
  doi: 10.1111/jth.12643
– ident: bibr21-1076029618770273
  doi: 10.1055/s-0037-1616068
– ident: bibr1-1076029618770273
  doi: 10.1016/j.jiac.2013.07.006
– ident: bibr25-1076029618770273
  doi: 10.1160/TH15-01-0053
– ident: bibr24-1076029618770273
  doi: 10.1186/s13054-015-0810-3
– ident: bibr8-1076029618770273
  doi: 10.1097/01.CCM.0000202209.42491.38
– ident: bibr10-1076029618770273
  doi: 10.1001/jama.2016.0287
– ident: bibr2-1076029618770273
  doi: 10.1186/s40560-016-0169-9
– ident: bibr22-1076029618770273
  doi: 10.1007/s00134-016-4621-z
– ident: bibr18-1076029618770273
  doi: 10.1007/s12185-015-1904-z
– ident: bibr13-1076029618770273
  doi: 10.1097/01.CCM.0000181296.53204.DE
– ident: bibr3-1076029618770273
  doi: 10.1111/jth.12596
– ident: bibr26-1076029618770273
  doi: 10.1055/s-2001-18867
– ident: bibr11-1076029618770273
  doi: 10.1186/s13054-016-1468-1
– ident: bibr7-1076029618770273
  doi: 10.1111/jth.13230
– ident: bibr6-1076029618770273
  doi: 10.1111/j.1538-7836.2004.00955.x
– volume: 42
  start-page: 92
  issue: 2
  year: 1994
  ident: bibr14-1076029618770273
  publication-title: Circ Shock
– ident: bibr4-1076029618770273
  doi: 10.1186/s13054-016-1415-1
– ident: bibr20-1076029618770273
  doi: 10.1016/j.thromres.2014.07.033
– ident: bibr17-1076029618770273
  doi: 10.1038/nrdp.2016.37
– ident: bibr16-1076029618770273
  doi: 10.1016/j.thromres.2008.07.006
– ident: bibr15-1076029618770273
  doi: 10.1097/01.CCM.0000295317.97245.2D
– ident: bibr19-1076029618770273
  doi: 10.1016/j.thromres.2009.08.017
– ident: bibr12-1076029618770273
  doi: 10.1136/bmjopen-2017-017046
– ident: bibr23-1076029618770273
  doi: 10.1007/s00134-016-4607-x
SSID ssj0019696
Score 2.3312252
Snippet Disseminated intravascular coagulation (DIC) in patients with sepsis represents a critical condition. Thus, a simple and rapid diagnosis is required. The...
SourceID pubmedcentral
proquest
pubmed
crossref
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1020
SubjectTerms Aged
Aged, 80 and over
Anticoagulants
Antithrombins - therapeutic use
Asian Continental Ancestry Group
Blood Coagulation Disorders - complications
Disseminated Intravascular Coagulation - blood
Female
Humans
Male
Mortality
Original
Sepsis
Sepsis - blood
Sepsis - drug therapy
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxNBEB-0gvgi2qo9rbIFKfhwJHvf-yQhtdSCRbCFvIXb3TkbaO_SXvKQP8b_1Zm9zTWx2Ned_YLZj9_Mzv4G4HMsK6vTIYYlFmSgVDF_VrZVmKVVrFWm0XYBsufZ6WVyNkkn3uHW-rDK9ZnoDmrbGPaRDwiHxDlzu6df57chZ43i11WfQuMpPGPqMg7pyie9weWYX7qYQw60VRvPlAMu4yJZ5DlTumxfSw-w5sOQyY24L3cVnbyClx5DilGn9NfwBOtd2BvVZD_frMSRcFGdzl2-C89_-MfzPfjzC-ftrA05W4dBK8ZN-Xt53XBO4pUoayvO6OLkhJRiQ2eCQK0YmeUCxboncfx9LGb1ZvuZET87gtZWsGdXHDs02tIoI_4HfHXX3JAJ7ka5YJhKAr3akr2By5NvF-PT0GdnCE2SRYsQdRmhVJjqMsbIRpp5YBRKO4yLYWlibch0S7TSpHql0yw30la2iHKMVFoSinsLO3VT4z6ITGJBJ4mx6bBKVIZKcq7DxFQyQhMXZQCDtXKmxlOXcwaN66n0bOX_qjOAL32LeUfb8Ujdg7W-p34Dt9P75RbAYS-mrcfvKaSLZkl1mPqf4GBCXbzrlkc_GPVP2DUvAsi3Fk5fgWm9tyX17MrRe2e5TAjHBXDES-x-Sv-b__vH5_8BXhDI6zh85QHsLO6W-JGA1EJ_crvlL0W6Gb4
  priority: 102
  providerName: ProQuest
Title Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin
URI https://journals.sagepub.com/doi/full/10.1177/1076029618770273
https://www.ncbi.nlm.nih.gov/pubmed/29695178
https://www.proquest.com/docview/2313718685
https://www.proquest.com/docview/2031415943
https://pubmed.ncbi.nlm.nih.gov/PMC6714750
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEB7ygNJLSZM-3KRBhRLowc3KL9mn4m6ypIGGkG7o3oz1cLOQtUNsH_bH9L92xq_udmnpybCSJbEzsj5pRt8H8N7lmZb-yNipCXGDkrl0WVlnduBnrowCaXSbIHsVXNx6lzN_tgV5fxem-wfLj5RWhSNqPtY0u-k0-rQLMuJTBCOHxEqEIEKWT3W1SNrT7l5Ug36h8HS9oMi2onzIpd3fbtuGXUcEPk7k3Xhy8306xB2IK6bNUqTU3GglsLnR5_pCtoFON5MsVzLFmsVrsgfPOtTJ4tZNnsOWyffhIM5xx71YshPW5IE2B-z78ORrF24_gJ_fzEM5L23S91BGs3GR_qjvC1IxXrI01-wSl1qSsGQrVmYIg1ms6sqwviV29mXM5vnq-3PFrltK15LRWTA7a_Brib3EdHP47rFY4Ka96WVKwBYL5HKt7AXcTs6n4wu703OwlRc4lW1k6hgeGV-mrnG0I4k5JjJcj9xwlCpXKtzseTKS6CyR9AOhuM506AjjRH6KuO8l7ORFbl4DC7gJ8dujtD_KvCgwESd1RE9l3DHKDVMLTnvjJKojOyfNjfuEd_zmf5rTgg_DGw8t0cc_6h719k56h00QKLuCxAd8C94NxThZKQKDtihqrENiAQggPWziVeseQ2fYPqJdEVog1hxnqEBE4Osl-fyuIQQPBPcQ-VlwQi72e0h_G_-b_614CE8RILb8v_wIdqrH2rxFEFbJY9gWM3HczR98fj6_ur75BWysL3E
linkProvider SAGE Publications
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VqQRcEG15GFpYJKjEwUrWbx9QFZJWSR9RBanUm-t9mEZq7VAnQvkx_IX-Rmb8akJFb71617srzezsNzuz3wB8snmihNvRZqwDdFASmx4rq8T03MQWoSe0KhNkR97gzDk8d8_X4LZ-C0NplbVNLAy1yiTdkbcRh9g-cbu7e9NfJlWNouhqXUKjVIsjvfiNLlv-ddhH-X62rIP9cW9gVlUFTOl41szUIrY0D7UrYltbyhLEXxJqrjp20ImlLSS6HI4IBS45FK7nS64SFVi-tkI3dojoAE3-umOjK9OC9W_7o9PvTdyCuGbKLEdK7Q2XAqNt-kafeOD7RCKzehDeQ7f3kzSXMs2Kw-_gBTyvUCvrlmq2AWs63YStbooe-_WC7bIij7S4oN-EJydVuH4L_vzQ03ySm1QfRGrFeln8c36VURXkBYtTxQ7xqKYSmGxJSxjCaNaV85lm9UisP-yxSbr8_0Sy05ISNmd0l8z6Bf7NcZYuvTy-vMmu0ekvZhkTMMYGsVhpewlnjyK5V9BKs1S_AeZxHaDtksrtJE7o6ZBTdUVHJtzS0g5iA9q1cCJZkaVTzY6riFf86P-K04AvzR_Tkijkgb7btbyjymTk0Z2CG_CxacbNThEclEU2xz5UbAABqINDvC7Vo5kMx0e07AcG-CuK03QgIvHVlnRyWRCKez53EDkasEsqdrek_63_7cPr_wBPB-OT4-h4ODp6B88QYgblpdU2tGY3c72DMG4m3ld7h8HFY2_Xv50WWL8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEB5BKlVcUGl5mBZYJFSJg6nXXnvto5UQtQWqClLRm-V9mEZq7ahODvkx_FdmbMckRCBOPuzs7Mqzj293Zr8BeBfwwqjQs25uYzygFAE9VjaFG4VFoJJIWdMGyF5Ep1fi_Dq87mJz6C1M9wfrDxRWhT1qFmua3TNTnHQ-RvzKyPMpV4mUxMfyEHaEwK1xADvp-Ov3Se9GIOqXNuiQIm2TNT_llo7NfWkLbG7HTK4FfjV70XgPHncgkqWt1Z_AA1vuw0Fa4gH6bsmOWRPW2dyX78Pul857fgA_v9lZPa1dStehrWHDKv-xuK0oKfGS5aVh57hzUkZKtmY0hqiWpXoxt2yliY3OhmxartefanbZMrTWjK522aiBozW2ktJD4Jv76g7P4E0rE8KpWKCWG2VP4Wr8cTI8dbv0DK4WkT93rcp9yxMbqjywvvEVEcEklhsviL1cB0rj2U2oRKHtExVGUnNTmNiX1k_CHGHcMxiUVWlfAIu4jXEp0Sb0CpFENuGU7FDogvtWB3HuwMnKOJnuuMsphcZtxju68j_N6cD7vsas5e34h-zRyt7ZavxliHsDSbkEQgfe9sU498ihgraoFihD3P-IBwWqeN4Oj74x1I_gVcYOyI2B0wsQr_dmSTm9afi9I8kFAjkHjmmI_e7S3_r_8n8F38Du5WicfT67-HQIjxD6tcy-_AgG8_uFfYXwaq5ed5PoF-T9G2k
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sepsis-Induced+Coagulopathy+and+Japanese+Association+for+Acute+Medicine+DIC+in+Coagulopathic+Patients+with+Decreased+Antithrombin+and+Treated+by+Antithrombin&rft.jtitle=Clinical+and+applied+thrombosis%2Fhemostasis&rft.au=Iba%2C+Toshiaki&rft.au=Arakawa%2C+Makoto&rft.au=Levy%2C+Jerrold+H.&rft.au=Yamakawa%2C+Kazuma&rft.date=2018-10-01&rft.pub=SAGE+Publications&rft.issn=1076-0296&rft.eissn=1938-2723&rft.volume=24&rft.issue=7&rft.spage=1020&rft.epage=1026&rft_id=info:doi/10.1177%2F1076029618770273&rft.externalDocID=10.1177_1076029618770273
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1076-0296&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1076-0296&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1076-0296&client=summon